144 related articles for article (PubMed ID: 12749728)
1. Proteomic prediction of disease outcome in cancer : clinical framework and current status.
Steinert R; von Hoegen P; Fels LM; Günther K; Lippert H; Reymond MA
Am J Pharmacogenomics; 2003; 3(2):107-15. PubMed ID: 12749728
[TBL] [Abstract][Full Text] [Related]
2. Proteomics in prostate cancer biomarker discovery.
Larkin SE; Zeidan B; Taylor MG; Bickers B; Al-Ruwaili J; Aukim-Hastie C; Townsend PA
Expert Rev Proteomics; 2010 Feb; 7(1):93-102. PubMed ID: 20121479
[TBL] [Abstract][Full Text] [Related]
3. Global proteomics profiling improves drug sensitivity prediction: results from a multi-omics, pan-cancer modeling approach.
Ali M; Khan SA; Wennerberg K; Aittokallio T
Bioinformatics; 2018 Apr; 34(8):1353-1362. PubMed ID: 29186355
[TBL] [Abstract][Full Text] [Related]
4. Proteomics for Early Diagnostics.
Mali SB
J Craniofac Surg; 2015 Jun; 26(4):1013-4. PubMed ID: 26080113
[TBL] [Abstract][Full Text] [Related]
5. Rationale and study design of the CardioGene Study: genomics of in-stent restenosis.
Ganesh SK; Skelding KA; Mehta L; O'Neill K; Joo J; Zheng G; Goldstein J; Simari R; Billings E; Geller NL; Holmes D; O'Neill WW; Nabel EG
Pharmacogenomics; 2004 Oct; 5(7):952-1004. PubMed ID: 15469413
[TBL] [Abstract][Full Text] [Related]
6. The role of proteomics in the diagnosis and outcome prediction in colorectal cancer.
Steinert R; Buschmann T; van der Linden M; Fels LM; Lippert H; Reymond MA
Technol Cancer Res Treat; 2002 Aug; 1(4):297-304. PubMed ID: 12625789
[TBL] [Abstract][Full Text] [Related]
7. Antibody-Based Proteomics.
Wingren C
Adv Exp Med Biol; 2016; 926():163-179. PubMed ID: 27686812
[TBL] [Abstract][Full Text] [Related]
8. Proteomics of cancer of hormone-dependent tissues.
Tyson DR; Ornstein DK
Adv Exp Med Biol; 2008; 630():133-47. PubMed ID: 18637489
[TBL] [Abstract][Full Text] [Related]
9. Predicting cancer drug response by proteomic profiling.
Ma Y; Ding Z; Qian Y; Shi X; Castranova V; Harner EJ; Guo L
Clin Cancer Res; 2006 Aug; 12(15):4583-9. PubMed ID: 16899605
[TBL] [Abstract][Full Text] [Related]
10. [Present possibilities and future development of clinical proteomics].
Lehmann S; Dupuy A; Peoc'h K; Roche S; Baudin B; Quillard M; Berger F; Briand G; Chwetzoff S; Dine G; Gonzalo P; Dastugue B; Sève M; Siest G; Beaudeux JL
Ann Biol Clin (Paris); 2007; 65(5):463-71. PubMed ID: 17913666
[TBL] [Abstract][Full Text] [Related]
11. Clinical proteomics in cancer: Where we are.
Panis C; Pizzatti L; Souza GF; Abdelhay E
Cancer Lett; 2016 Nov; 382(2):231-239. PubMed ID: 27561426
[TBL] [Abstract][Full Text] [Related]
12. Clinical potential of proteomics in the diagnosis of ovarian cancer.
Ardekani AM; Liotta LA; Petricoin EF
Expert Rev Mol Diagn; 2002 Jul; 2(4):312-20. PubMed ID: 12138495
[TBL] [Abstract][Full Text] [Related]
13. Application of proteomic technologies for prostate cancer detection, prognosis, and tailored therapy.
Fredolini C; Liotta LA; Petricoin EF
Crit Rev Clin Lab Sci; 2010; 47(3):125-38. PubMed ID: 20858067
[TBL] [Abstract][Full Text] [Related]
14. Proteomic Approaches for Biomarker Panels in Cancer.
Tanase C; Albulescu R; Neagu M
J Immunoassay Immunochem; 2016; 37(1):1-15. PubMed ID: 26565430
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of Preoperative Serum Levels of Five Tumor Markers (Carcinoembryonic Antigen, CA19-9, Alpha-fetoprotein, CA72-4, and CA125) in Gastric Cancer.
Kim JH; Jun KH; Jung H; Park IS; Chin HM
Hepatogastroenterology; 2014 May; 61(131):863-9. PubMed ID: 26176088
[TBL] [Abstract][Full Text] [Related]
16. Proteomics and protein analyses of ovine and caprine body fluids: current studies and future promises.
Mavromati J; Cash P; Restelli L; Soler L
Curr Protein Pept Sci; 2014 Feb; 15(1):45-55. PubMed ID: 24555895
[TBL] [Abstract][Full Text] [Related]
17. Application of proteomic technologies to tumor analysis.
Misek DE; Imafuku Y; Hanash SM
Pharmacogenomics; 2004 Dec; 5(8):1129-37. PubMed ID: 15584879
[TBL] [Abstract][Full Text] [Related]
18. Proteomics technologies for the global identification and quantification of proteins.
Brewis IA; Brennan P
Adv Protein Chem Struct Biol; 2010; 80():1-44. PubMed ID: 21109216
[TBL] [Abstract][Full Text] [Related]
19. Cancer proteomics: Serum diagnostics for tumor marker discovery.
Rai AJ; Chan DW
Ann N Y Acad Sci; 2004 Jun; 1022():286-94. PubMed ID: 15251974
[TBL] [Abstract][Full Text] [Related]
20. A proteomic signature of ovarian cancer tumor fluid identified by highthroughput and verified by targeted proteomics.
Poersch A; Grassi ML; Carvalho VP; Lanfredi GP; Palma CS; Greene LJ; de Sousa CB; Carrara HHA; Candido Dos Reis FJ; Faça VM
J Proteomics; 2016 Aug; 145():226-236. PubMed ID: 27222041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]